• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞吸附剂 CytoSorb®在急性肝衰竭患者中的血液吸附治疗:病例系列研究。

Haemoadsorption by CytoSorb® in patients with acute liver failure: A case series.

机构信息

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Fundeni Clinical Institute, Department of Anaesthesia and Intensive Care, Bucharest, Romania.

出版信息

Int J Artif Organs. 2021 Aug;44(8):560-564. doi: 10.1177/0391398820981383. Epub 2020 Dec 10.

DOI:10.1177/0391398820981383
PMID:33302765
Abstract

Acute liver failure (ALF) is a life-threatening disease associated with multi-organ failure and increased mortality. Severe inflammation is now considered the main pathophysiological mechanism for organ dysfunction, thus rebalancing pro- and anti- inflammatory cytokines may improve liver function and outcome. The aim of this study was to assess the clinical effects of a haemoadsorption column on biochemical parameters in patients with ALF. We prospectively included 28 patients with ALF who were treated with three consecutive sessions of continuous venovenous haemofiltration in combination with CytoSorb. Our results show an improvement in liver functional tests and a decrease in Creactive protein. Thrombocytopenia remains one of the most important side effects of this treatment and careful consideration should be made before initiation of treatment.

摘要

急性肝衰竭(ALF)是一种危及生命的疾病,可导致多器官衰竭和死亡率增加。严重的炎症现在被认为是器官功能障碍的主要病理生理机制,因此,重新平衡促炎和抗炎细胞因子可能会改善肝功能和预后。本研究旨在评估血液吸附柱对 ALF 患者生化参数的临床疗效。我们前瞻性地纳入了 28 例 ALF 患者,这些患者接受了连续三次的连续静脉-静脉血液滤过联合 CytoSorb 治疗。我们的结果显示,肝功能试验有所改善,C 反应蛋白降低。血小板减少仍然是这种治疗的最重要副作用之一,在开始治疗前应慎重考虑。

相似文献

1
Haemoadsorption by CytoSorb® in patients with acute liver failure: A case series.细胞吸附剂 CytoSorb®在急性肝衰竭患者中的血液吸附治疗:病例系列研究。
Int J Artif Organs. 2021 Aug;44(8):560-564. doi: 10.1177/0391398820981383. Epub 2020 Dec 10.
2
Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.血液吸附治疗儿科重症监护室多器官功能衰竭患者的疗效分析:两例报告并文献复习
Artif Organs. 2021 Dec;45(12):1582-1593. doi: 10.1111/aor.14047. Epub 2021 Aug 12.
3
Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection.内毒素和细胞因子吸附血液滤过器在革兰氏阴性菌感染致脓毒症急性肾损伤中的应用。
Hong Kong Med J. 2013 Dec;19(6):491-7. doi: 10.12809/hkmj133910. Epub 2013 May 6.
4
Molecular adsorbent recirculating system (MARS).分子吸附再循环系统(MARS)。
Ann Acad Med Singap. 2004 May;33(3):329-35.
5
Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model.血液吸附在实验模型中减少了体外肾灌注期间的炎症反应并改善了血流。
J Transl Med. 2017 Oct 25;15(1):216. doi: 10.1186/s12967-017-1314-5.
6
Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb.细胞因子、血流动力学和微循环变化在接受连续肾脏替代治疗和细胞因子吸附血液净化的脓毒症/脓毒性休克患者中。
Blood Purif. 2020;49(1-2):107-113. doi: 10.1159/000502540. Epub 2019 Aug 21.
7
Detoxification as a treatment goal in hepatic failure.解毒作为肝衰竭的治疗目标。
Liver Int. 2011 Sep;31 Suppl 3:1-4. doi: 10.1111/j.1478-3231.2011.02587.x.
8
Successful Treatment of Rhabdomyolysis-Associated Acute Kidney Injury with Haemoadsorption and Continuous Renal Replacement Therapy.血液吸附联合连续性肾脏替代疗法成功治疗横纹肌溶解症相关急性肾损伤
Case Rep Pediatr. 2021 Oct 4;2021:2148024. doi: 10.1155/2021/2148024. eCollection 2021.
9
Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis.细胞吸附柱和分子吸附再循环系统用于肝衰竭的人工肝支持:一项回顾性倾向匹配分析
J Clin Med. 2023 Mar 14;12(6):2258. doi: 10.3390/jcm12062258.
10
[Efficacy and safety of coupled plasma filtration adsorption combined with continuous veno-venous hemofiltration for multiple organ dysfunction syndrome patients with acute liver failure].配对血浆滤过吸附联合连续性静脉-静脉血液滤过治疗急性肝衰竭合并多器官功能障碍综合征患者的疗效及安全性
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Jan;19(1):47-9.

引用本文的文献

1
Critical risks of haemoadsorption for COVID-19 patients and directions for future evaluations: a nationwide propensity score matched cohort study.COVID-19患者血液吸附的关键风险及未来评估方向:一项全国性倾向评分匹配队列研究
Sci Rep. 2025 Aug 9;15(1):29184. doi: 10.1038/s41598-025-13860-0.
2
Acute liver failure in patients admitted to the intensive care unit-a Viennese retrospective single-center analysis.重症监护病房收治患者的急性肝衰竭——一项维也纳单中心回顾性分析
Wien Klin Wochenschr. 2025 May 26. doi: 10.1007/s00508-025-02539-1.
3
Reply to Riva et al. Comment on "Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios. 2024, , 2853".
回复里瓦等人。对“加斯帕里等人。肝移植或广泛肝切除术后肝功能不全的血液净化:远非最佳情况。2024年,,2853”的评论
J Clin Med. 2025 Jan 27;14(3):822. doi: 10.3390/jcm14030822.
4
Comment on Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios. 2024, , 2853.对加斯帕里等人的评论:肝移植或广泛肝切除术后肝功能不全的血液净化:远离最佳情况。2024年,,2853。
J Clin Med. 2025 Jan 23;14(3):716. doi: 10.3390/jcm14030716.
5
The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry.《COSMOS 细胞吸附治疗危重症患者的注册研究:一项国际性前瞻性注册研究方案》
JMIR Res Protoc. 2024 Nov 5;13:e55880. doi: 10.2196/55880.
6
Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios.肝移植或广泛肝切除术后肝功能障碍的血液净化:远离最佳情况。
J Clin Med. 2024 May 12;13(10):2853. doi: 10.3390/jcm13102853.
7
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure.细胞吸附剂 CytoSorb 在慢加急性肝衰竭患者中的应用。
Sci Rep. 2024 May 17;14(1):11309. doi: 10.1038/s41598-024-61658-3.
8
Graft repair during machine perfusion: a current overview of strategies.机器灌注期间的移植物修复:策略的当前概述。
Curr Opin Organ Transplant. 2024 Aug 1;29(4):248-254. doi: 10.1097/MOT.0000000000001151. Epub 2024 May 10.
9
Hemoadsorption in Organ Preservation and Transplantation: A Narrative Review.血液吸附在器官保存与移植中的应用:一篇叙述性综述
Life (Basel). 2023 Dec 29;14(1):65. doi: 10.3390/life14010065.
10
Liver-Support Therapies in Critical Illness-A Comparative Analysis of Procedural Characteristics and Safety.危重症中的肝脏支持疗法——程序特征与安全性的比较分析
J Clin Med. 2023 Jul 13;12(14):4669. doi: 10.3390/jcm12144669.